Product/Composition:- | Enalapril tablets |
---|---|
Strength:- | 2.5 mg, 5 mg, 10 mg, 20 mg |
Form:- | Tablet |
Reference Brands:- | Vasotec(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Enalapril tablets are ACE inhibitors that block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Benefits include lowering blood pressure, reducing heart failure symptoms, preventing strokes, and protecting kidney function, thereby improving cardiovascular health and decreasing the risk of hypertension-related complications.
Enalapril tablets are approved in both the US and EU, supported by detailed dossiers demonstrating safety, efficacy, and quality, compliant with GMP standards. In the US, they are regulated by the FDA, while in the EU, EMA oversees approval processes. These dossiers include clinical trial data, stability, and manufacturing information. Enalapril is widely prescribed for hypertension and heart failure, with market authorization based on rigorous evaluation. For comprehensive regulatory insights, licensing requirements, and approved dossiers for enalapril tablets, visit Pharmatradz. Stay informed about the latest updates on regulatory approvals and market access pathways for enalapril globally.